Pfizer (PFE)
Developer of prescription medicines and vaccines across oncology, internal medicine, immunology and infectious disease.
$27.77
vs last close+0.02 (+0.09%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
$0.79
Revenue estimate
$15.93B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.63$0.92$0.78$0.87$0.66$0.75$0.77Pending
Estimate$0.47$0.67$0.58$0.63$0.57$0.72$0.68$0.79
Surprise+33.6%+38.1%+34.5%+37.4%+16.4%+3.9%+12.9%—
RevenueReportedEstimate
Feb '25Apr '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$17.76B$13.72B$14.65B$16.65B$17.56B$14.45B$15.03BPending
Estimate$17.35B$13.92B$13.56B$16.50B$16.85B$13.84B$14.40B$15.93B
Surprise+2.4%−1.5%+8.1%+0.9%+4.2%+4.4%+4.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.63 | — | — |
| Sep 2027 | $0.79 | — | — |
| Jun 2027 | $0.64 | — | — |
| Mar 2027 | $0.63 | — | — |
| Dec 2026 | $0.71 | — | — |
| Nov 2026 | $0.79 | — | — |
| Aug 2026 | $0.68 | $0.77 | +12.9% |
| May 2026 | $0.72 | $0.75 | +3.9% |
| Feb 2026 | $0.57 | $0.66 | +16.4% |
| Nov 2025 | $0.63 | $0.87 | +37.4% |
| Aug 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Jan 2023 | |||
| Nov 2022 | |||
| Jul 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Jan 2018 | |||
| Oct 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Jan 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.63 | — | — | $15.87B | — | — | — |
| Sep 2027 | $0.79 | — | — | $15.58B | — | — | — |
| Jun 2027 | $0.64 | — | — | $14.02B | — | — | — |
| Mar 2027 | $0.63 | — | — | $13.27B | — | — | — |
| Dec 2026 | $0.71 | — | — | $16.87B | — | — | — |
| Nov 3, 2026 | $0.79 | — | — | $15.93B | — | — | — |
| Aug 4, 2026 | $0.68 | $0.77 | +12.9% | $14.40B | $15.03B | +4.4% | +1.5% |
| May 5, 2026 | $0.72 | $0.75 | +3.9% | $13.84B | $14.45B | +4.4% | +0.6% |
| Feb 3, 2026 | $0.57 | $0.66 | +16.4% | $16.85B | $17.56B | +4.2% | −3.3% |
| Nov 4, 2025 | $0.63 | $0.87 | +37.4% | $16.50B | $16.65B | +0.9% | −1.5% |
| Aug 5, 2025 | |||||||
| Apr 29, 2025 | |||||||
| Feb 4, 2025 | |||||||
| Oct 29, 2024 | |||||||
| Jul 30, 2024 | |||||||
| May 1, 2024 | |||||||
| Jan 30, 2024 | |||||||
| Oct 31, 2023 | |||||||
| Aug 1, 2023 | |||||||
| May 2, 2023 | |||||||
| Jan 31, 2023 | |||||||
| Nov 1, 2022 | |||||||
| Jul 28, 2022 | |||||||
| May 3, 2022 | |||||||
| Feb 8, 2022 | |||||||
| Nov 2, 2021 | |||||||
| Jul 28, 2021 | |||||||
| May 4, 2021 | |||||||
| Feb 2, 2021 | |||||||
| Oct 27, 2020 | |||||||
| Jul 28, 2020 | |||||||
| Apr 28, 2020 | |||||||
| Jan 28, 2020 | |||||||
| Oct 29, 2019 | |||||||
| Jul 29, 2019 | |||||||
| Apr 30, 2019 | |||||||
| Jan 29, 2019 | |||||||
| Oct 30, 2018 | |||||||
| Jul 31, 2018 | |||||||
| May 1, 2018 | |||||||
| Jan 30, 2018 | |||||||
| Oct 31, 2017 | |||||||
| Aug 1, 2017 | |||||||
| May 2, 2017 | |||||||
| Jan 31, 2017 | |||||||
| Nov 1, 2016 | |||||||
| Aug 2, 2016 | |||||||
| May 3, 2016 | |||||||
| Feb 2, 2016 | |||||||
| Oct 27, 2015 | |||||||
| Jul 28, 2015 |